Catalyst Pharmaceuticals (CPRX) Prepaid Assets (2010 - 2026)
Catalyst Pharmaceuticals posted quarterly Prepaid Assets of $1.1 million for Q1 2026, up 150.22% year-on-year from $452000.0 in Q1 2025, and down 80.88% on a QoQ basis from $5.9 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 17 years of Prepaid Assets data on file, last reported at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 150.22% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 150.22% YoY), and the FY2025 full-year result was $5.9 million, up 1071.49% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.1 million, down from $5.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $23.6 million in Q2 2024 and bottomed at $452000.0 in Q1 2025.
- The 5-year median for Prepaid Assets is $4.3 million (2022), against an average of $5.7 million.
- Peak annual rise in Prepaid Assets reached 1071.49% in 2025, while the deepest fall reached 96.71% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $5.2 million in 2022, then plunged by 74.22% to $1.3 million in 2023, then tumbled by 62.09% to $505000.0 in 2024, then soared by 1071.49% to $5.9 million in 2025, then plunged by 80.88% to $1.1 million in 2026.
- The last three Prepaid Assets figures came in at $1.1 million (Q1 2026), $5.9 million (Q4 2025), and $540000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 5.92 Mn |
| Sep 30, 2025 | 540,000.00 |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 452,000.00 |
| Dec 31, 2024 | 505,000.00 |
| Sep 30, 2024 | 509,000.00 |
| Jun 30, 2024 | 23.55 Mn |
| Mar 31, 2024 | 13.75 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 13.96 Mn |
| Jun 30, 2023 | 8.63 Mn |
| Mar 31, 2023 | 6.93 Mn |
| Dec 31, 2022 | 5.17 Mn |
| Sep 30, 2022 | 3.78 Mn |
| Jun 30, 2022 | 4.33 Mn |
| Mar 31, 2022 | 5.02 Mn |
| Dec 31, 2021 | 4.35 Mn |
| Sep 30, 2021 | 4.43 Mn |
| Jun 30, 2021 | 7.64 Mn |
| Mar 31, 2021 | 8.24 Mn |
| Dec 31, 2020 | 8.33 Mn |
| Sep 30, 2020 | 5.61 Mn |
| Jun 30, 2020 | 7.52 Mn |
| Mar 31, 2020 | 6.06 Mn |
| Dec 31, 2019 | 4.35 Mn |
| Sep 30, 2019 | 3.34 Mn |
| Jun 30, 2019 | 1.49 Mn |
| Mar 31, 2019 | 1.88 Mn |
| Dec 31, 2018 | 1.65 Mn |
| Sep 30, 2018 | 191,291.00 |
| Jun 30, 2018 | 60,707.00 |
| Mar 31, 2018 | 992,828.00 |
| Dec 31, 2017 | 58,281.00 |
| Sep 30, 2017 | 91,514.00 |
| Jun 30, 2017 | 33,556.00 |
| Mar 31, 2017 | 457,487.00 |
| Dec 31, 2016 | 36,444.00 |
| Sep 30, 2016 | 78,323.00 |
| Jun 30, 2016 | 19,127.00 |
| Mar 31, 2016 | 19,319.00 |
| Dec 31, 2015 | 1.50 Mn |
| Sep 30, 2015 | 53,243.00 |
| Jun 30, 2015 | 861,268.00 |
| Mar 31, 2015 | 277,723.00 |
| Dec 31, 2014 | 10,870.00 |
| Sep 30, 2014 | 45,046.00 |
| Jun 30, 2014 | 842,094.00 |
| Mar 31, 2014 | 6,686.00 |
| Dec 31, 2013 | 1.61 Mn |
| Sep 30, 2013 | 88,043.00 |
| Jun 30, 2013 | 131,995.00 |
| Dec 31, 2012 | 1.31 Mn |
| Mar 31, 2012 | 242,722.00 |
| Dec 31, 2011 | 199,116.00 |
| Sep 30, 2011 | 113,820.00 |
| Jun 30, 2011 | 166,066.00 |
| Dec 31, 2010 | 166,221.00 |